Tokyo, Dec. 2 (Jiji Press)–Actual drug prices medical institutions in Japan paid to wholesalers in September were some 8 pct lower than the state-set official prices, a health ministry survey report showed Wednesday.
The report was shared at a meeting of the Central Social Insurance Medical Council, which advises the health minister.
Japan revises official drug prices and medical fees every two years in principle, but it plans to revise them every year from fiscal 2021, which begins in April next year, hoping to optimize medical bills and reduce burdens on the people.
The government is expected to lower official drug prices in fiscal 2021 as planned on the basis of the report, despite concerns over the move among some people in related industry sectors amid the spread of the novel coronavirus.
In its basic economic and fiscal policy guidelines adopted in July, the government said it will decide whether to revise drug prices after taking into consideration a full range of factors including the impact of the virus.
For the report, the ministry conducted a survey on a limited number of drug wholesalers and medical institutions.